First Time Loading...
S

Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212

Watchlist Manager
Shanghai Aohua Photoelectricity Endoscope Co Ltd
SSE:688212
Watchlist
Price: 56.1 CNY 1.8% Market Closed
Updated: May 9, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shanghai Aohua Photoelectricity Endoscope Co Ltd

Wall Street analysts forecast Shanghai Aohua Photoelectricity Endoscope Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Aohua Photoelectricity Endoscope Co Ltd is 75.82 CNY with a low forecast of 60.34 CNY and a high forecast of 91.35 CNY.

Lowest Forecast
Wall Street Target
60.34 CNY
8% Upside
Average Forecast
Wall Street Target
75.82 CNY
35% Upside
Highest Forecast
Wall Street Target
91.35 CNY
63% Upside
Lowest
Price Target
60.34 CNY
8% Upside
Average
Price Target
75.82 CNY
35% Upside
Highest
Price Target
91.35 CNY
63% Upside
Shanghai Aohua Photoelectricity Endoscope Co Ltd Competitors:
Price Targets
TCMD
Tactile Systems Technology Inc
51% Upside
RMD
Resmed Inc
0% Downside
DEMANT
Demant A/S
7% Upside
I
099190
I Sens Inc
61% Upside
TCMD
Tactile Systems Technology Inc
51% Upside
RMD
Resmed Inc
0% Downside
DEMANT
Demant A/S
7% Upside
I
099190
I Sens Inc
61% Upside
NYXH
Nyxoah SA
82% Upside
2235
MicroTech Medical Hangzhou Co Ltd
51% Upside
PODD
Insulet Corp
35% Upside
SRTS
Sensus Healthcare Inc
81% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Aohua Photoelectricity Endoscope Co Ltd

For the last 3 years the compound annual growth rate for Shanghai Aohua Photoelectricity Endoscope Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 48%.

14%
Past Growth
48%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shanghai Aohua Photoelectricity Endoscope Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shanghai Aohua Photoelectricity Endoscope Co Ltd

For the last 3 years the compound annual growth rate for Shanghai Aohua Photoelectricity Endoscope Co Ltd's net income is -26%. The projected CAGR for the next 3 years is 105%.

-26%
Past Growth
105%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's stock price target?
Price Target
75.82 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai Aohua Photoelectricity Endoscope Co Ltd is 75.82 CNY with a low forecast of 60.34 CNY and a high forecast of 91.35 CNY.

What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's Revenue forecast?
Projected CAGR
48%

For the last 3 years the compound annual growth rate for Shanghai Aohua Photoelectricity Endoscope Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 48%.

What is Shanghai Aohua Photoelectricity Endoscope Co Ltd's Net Income forecast?
Projected CAGR
105%

For the last 3 years the compound annual growth rate for Shanghai Aohua Photoelectricity Endoscope Co Ltd's net income is -26%. The projected CAGR for the next 3 years is 105%.

ALPHA SPREAD
Join more than 135,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.